Compounds containing a 1,2,3-triazole-substituted benzenesulfonamide were prepared and found to be potent and selective human beta3-adrenergic receptor agonists. The most interesting compound, trifluoromethylbenzyl analogue 12e (beta3 EC50 = 3.1 nM with >1500-fold selectivity over binding to both beta1- and beta2 receptors), stimulates lipolysis in the rhesus monkey (ED50 = 0.36 mg/kg) and is 25% orally bioavailable in the dog.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1016/s0960-894x(00)00422-4 | DOI Listing |
Publication Analysis
Top Keywords
human beta3-adrenergic
8
beta3-adrenergic receptor
8
receptor agonists
8
agonists 123-triazole-substituted
4
123-triazole-substituted benzenesulfonamides
4
benzenesulfonamides compounds
4
compounds 123-triazole-substituted
4
123-triazole-substituted benzenesulfonamide
4
benzenesulfonamide prepared
4
prepared potent
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!